IBM (IBM) Rebounds 5% on ServiceNow AI Deal — Can It Clear $267 Resistance?

TradingKey - IBM (NYSE: IBM) is currently at $264.05. It is recovering from an earlier intra-week low of $249 following five sessions of compression initiated with Accenture’s June 18 guidance cut that triggered a sell-off across IT services. That was exacerbated by the market’s negative reading of an IBM Institute for Business Value study that was essentially read as an AI demand warning. IBM gained 5.15% on June 23 based on three positive, tangible developments. Those included an expanded multiyear service collaboration in which IBM’s watsonx, Red Hat, and its AI automation stack are embedded into the ServiceNow AI Platform. Another was the launch of an OpenAI-linked service for the identification of software vulnerabilities in real-time. 

In addition, new IBM Z tools were added that will expand automated reach among critical infrastructure clients. On the 4H timeframe IBM is now testing EMA50 resistance at $267.04 after holding above $259.17 EMA200, with RSI hovering between 37.53 and 50.99 following the recovery.

Three Events That Broke IBM From $332 to $249 — And Why the AI Threat Is Real but Misread

The compression in IBM’s shares from its most recent high of $332 to a low of $249 was triggered by three separate negative events that piled up on each other in quick order. IBM stock first tumbled 13.2% in a single session, its steepest plunge in one day since October 2000, when, in February, Anthropic declared that Claude Code would help modernise COBOL, the programming language behind many of IBM’s profitable mainframe systems. This news erased around $40 billion in IBM market capitalisation. Investors were left wondering: If AI could automate legacy code modernisation, what portion of IBM’s consulting and software businesses is now potentially structurally exposed? And the stock repriced from around 26.5x earnings to a lower multiple.

The company’s first-quarter FY26 earnings report on April 22 then threw another wrench in the works. Revenue came in at $15.92 billion with 9% growth, exceeding expectations; and software revenue totaled $7.05 billion and increased 11%, also beating estimates. But growth decelerated from the 12.2% rate in the prior quarter. Moreover, IBM said that its consulting business had been the growth engine for a $12.5 billion generative AI backlog as the company reportedly sought to land new customers in the space with the aim of getting them on to its software platform. Now investors saw indications that AI tools could be displacing the very type of engagements that helped drive IBM clients onto its software platform.

The June 17 IBV study introduced yet another downside. With 91% of enterprise executives saying they didn’t fully understand their AI use cases and 71% citing the difficult nature of vendor lock-in, the findings were framed by IBM as a sales pitch for its governance products. But Wall Street analysts interpreted them as signs of a deceleration in AI demand. IBM subsequently became an unintended victim of the June 18 Accenture downward guidance revision, resulting in a broad selloff across the IT services sector.

The ServiceNow Partnership and Watsonx Embedding — Why June 23 Matters

June 23's rally wasn't simply based on sentiment, but it did mark the latest chapter in a long-term, multiyear build-out of one of IBM's most meaningful partnerships: with ServiceNow on the workflow automation front. IBM has now put its Watsonx, Red Hat OpenShift, Instana, Ansible and other software tools inside ServiceNow's enterprise AI Platform, which is being used by CIOs to manage IT and automate business and employee workflows. 

Put another way, IBM has translated the management thesis, which was repeated on every call, of embed AI platform in mission-critical workflows, into an actual partnership with an actual named deal for an outfit that is already working with over 8,100 enterprises, that processes trillions of dollars in workflow transactions annually. The two parties expect to have joint solutions available by the latter part of 2026.

There was also the fact that security services to detect software vulnerabilities in real-time from OpenAI and automation tooling for IBM's Z mainframe for clients in critical infrastructure industries were two additional examples of the larger theme that has been repeated by IBM since the February hype cycle around Claude Code, namely that AI is going to be another compounding source of growth for IBM in the highly regulated space, rather than a threat to its business. 

Given that IBM has $12.5 billion of generative AI backlog, compared with just a little under $2 billion going into calendar year 2025, we believe that clients are spending money to get IBM's help building and governing AI rather than trying to replace the tool, which creates the tension between that view and COBOL cannibalisation that has yet to be resolved, but will become clearer as the next quarter(s) of IBM Consulting results come out.

IBM Technical Setup — EMA200 at $259.17 Holds, EMA50 Resistance at $267, Target $279.90

The IBM 4H $264.05 price holds above the EMA200 ($259.17) while pushing up against the EMA50 resistance at $267.04 after bouncing off $249 lows. Rising (black) trendline has created higher lows. The RSI 37.53 to 50.99 is neutral with room for expansion and has no major divergence; the market is relatively balanced, not looking to breakout or start another selling wave, more consolidating.

IBM Price Chart - Source: Tradingview

A breakout higher than $267.00 is opening up $279.90 and $293 is possible. A breakdown below EMA200 ($259.20) could result in a revisit of $250.

• Entry:  Long above $267.00 — EMA50 resistance cleared
• Target 1:  $279.90 — prior swing high zone
• Target 2:  $293 — channel extension
• Stop Loss:  Close below $259.20 — EMA200 support fails
• Key levels:  EMA200 $259.17 = floor | EMA50 $267.04 = gate | $249 = recent low

Bottom Line

IBM up 5.15% from its $249 low from June 23, as the company announced ServiceNow AI platform partnership, an OpenAI-connected cybersecurity offering, and IBM Z mainframes; this is showing the fruits of adding watsonx to critical workflow, recognized by the partnership. The IBM stock price of $264.05 is moving toward $267.04, a major resistance from EMA50; $259.17 from EMA200 is a support floor.

The AI backlog has grown from $2B to $12.5B in a single year, a powerful bullish signal for the fear of COBOL cannibalization. A close above $267.00 targets $279.90; with stops below $259.20. The Consulting slowdown pace versus the pace of the AI backlog's conversion will be the fundamental debate coming out of Q2 earnings.